Tacrolimus (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Tacrolimus drug offered from Mylan Institutional Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
NON-PROPRIETARY NAME: | Tacrolimus |
SUBSTANCE NAME: | TACROLIMUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-11-15 |
END MARKETING DATE: | 0000-00-00 |
Tacrolimus HUMAN PRESCRIPTION DRUG Details:
Item Description | Tacrolimus from Mylan Institutional Inc. |
LABELER NAME: | Mylan Institutional Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2010-11-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51079-817_478ffcf5-42c6-4275-8571-e8ade81fa7a5 |
PRODUCT NDC: | 51079-817 |
APPLICATION NUMBER: | ANDA090596 |
Other TACROLIMUS Pharmaceutical Manufacturers / Labelers: